Jim Hoffman: How Poor Efferocytosis Self-Sufficiency Causes Circulating Blood Levels of NETs Rising
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, reposted Muhammad HARIS Baig on LinkedIn:
“Poor efferocytosis self-sufficiency also causes a rise in circulating blood levels of extracellular chromatin/NETs that helps to facilitate experimental tumor growth, cancer-associated thrombosis and cancer metastasis. Digesting the extracellular chromatin with DNase has been demonstrated to improve the efficacy of existing anti-cancer therapies in tumor models and is going to be co-administered and trialed for human cancer.
See the attached very enlightening presentations by Mikala Egeblad, using Intravital Fluorescent Microscopy.”
Watch presentations using these links:
Quoting Muhammad HARIS Baig’s post:
“Role of Apoptosis Failure in Cancer Progression
Apoptosis is the body’s natural system for removing damaged or abnormal cells.
When this process breaks down, genetically unstable cells survive and continue dividing.
Over time, these cells collect mutations, escape normal growth control, and move one step closer to cancer.
How apoptosis failure drives cancer
p53 mutations
Loss of DNA damage sensing and cell cycle control
Bcl 2 overexpression
Blocks mitochondrial mediated cell death
Caspase inactivation
Prevents execution of programmed cell death
Genomic instability
Progressive accumulation of mutations
The outcome is clear. Abnormal cells avoid death, tumors grow, therapies fail, and disease progresses.
Defects in apoptotic pathways sit at the core of cancer biology and remain critical targets for modern anticancer therapies.”
Get the latest from Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?